GDF15 and metabolic dysfunction-associated steatotic liver disease: Nevertheless, the potential relationship between circulating levels of GDF15 and key features of MASLD being predisposed to atherosclerotic CV disease, such as an altered atherogenic profile, has not been fully explored.